About Pharmica
Pharmica is a Healthcare company based in Sparta (United States) founded in 2005, and was acquired by ProPharma Group in October 2021. Provider of clinical development supply chain, regulatory, and consulting services for biopharma sector. Its chief executive, as recorded, is Nilay Shah. Its focus areas include Biopharma Outsourcing, Diversified and Biologics. Its competitors include Catalent, Surrozen and Curia; 1 of its 3 listed competitors has raised funding.
Company details
Pharmica was founded in 2005 and is located in Sparta, United States. Operations focus on the biopharma sector, where clinical development and supply chain management are handled alongside regulatory support and consulting services. These offerings assist companies in navigating complex processes from early-stage trials to market compliance. Expertise is applied across various biopharmaceutical projects to ensure efficient workflows and adherence to standards.
- Headquarters Sparta, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pharmicaconsulting.com
- Social LinkedIn X Facebook
- Acquired by ProPharma Group (Oct 2021)
- Investors
- Acquired byProPharma Group
(Oct 2021)
Investors in Pharmica
Pharmica has secured backing from 1 investor. Prominent investors backing the company include ProPharma Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device | 2001 | propharmagroup.com | Saint Paul, United States |
Investor details for Pharmica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Pharmica
3 people are tracked at Pharmica (3 in leadership).
| Name | Role | Group |
|---|---|---|
Matt Kiernan | Owner | Leadership |
Eric Lake | Owner | Leadership |
Nilay Shah | CEO | Leadership |
Complete people profiles for Pharmica
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Pharmica
2 dated milestones of Pharmica across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Pharmica is founded.
- Exit Acquired by ProPharma Group.
Competitors of Pharmica
Pharmica has 3 listed competitors in our database, 1 of them funded. They include Catalent, Surrozen and Curia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| catalent.com | 2007 | Somerset, United States | 9,390 | CDMO offering drug and biologics development services | ||
| surrozen.com | 2016 | San Francisco, United States | $133M | 80 | Selective Wnt agonists are developed for human tissue regeneration. | |
| curiaglobal.com | 1991 | Albany, United States | 1,918 | Drug research, development, testing, and consulting services are provided. |
Detailed competitors of Pharmica
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Pharmica (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pharmica
Complete news archive for Pharmica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmica
Pharmica was founded in 2005.
Pharmica is headquartered in Sparta, United States.
Nilay Shah is the CEO of Pharmica, as recorded in our data.
Pharmica was founded in 2005 and is located in Sparta, United States. Operations focus on the biopharma sector, where clinical development and supply chain management are handled alongside regulatory support and consulting services. These offerings assist companies in navigating complex processes from early-stage trials to market compliance. Expertise is applied across various biopharmaceutical projects to ensure efficient workflows and adherence to standards.
Pharmica has 1 investor. Key investors include ProPharma Group.
Yes. Pharmica was acquired by ProPharma Group in October 2021.